RecruitingAsthma
Use of Biologics for Severe Asthma in Hong Kong
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.
Sponsor: Chinese University of Hong Kong
You may qualify if…
- ✓ Patients aged 18 years or older.
- ✓ Patients diagnosed with severe asthma per the Global Initiative for Asthma (GINA) guidelines.
- ✓ Patients who have received biologic therapy for treatment of asthma (including those who received just one dose to allow assessment of the reason for withdrawal)
You may not qualify if…
- ✕ \- Patients with respiratory diseases with other known significant respiratory diseases, including tuberculosis (TB)-destroyed lung parenchyma, history of lung resection and lung cancer
Source: ClinicalTrials.gov · NCT06778746 · last updated 2026-03-19